Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking a Sr. Manager/Associate Director for Regulatory Program Management to support innovative treatments for genetic diseases. In this pivotal role, you will collaborate with cross-functional teams to drive regulatory submissions and ensure timely project execution. Your expertise in regulatory project management and attention to detail will be crucial in navigating the complexities of NDA and MAA filings. Join a dynamic and patient-focused environment where your contributions can make a real difference in the lives of those affected by genetic conditions. This role offers opportunities for rapid career advancement and a collaborative, data-driven workplace culture.
QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.
Our business is inspired by our values:
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.
We are seeking a Sr. Manager/Associate Director, Regulatory Program Management to support the Achondroplasia and related skeletal dysplasia regulatory team. This individual will partner closely with the Sr. Director, Program Management, SVP, Regulatory Affairs, and cross-functional team members to enable delivering on key regulatory and filing goals for the program. This position requires understanding of and experience in biotech/drug development, regulatory filings and project management for late-stage clinical programs. The ideal candidate will have exceptional attention to detail and organizational skills and be able to organize projects effectively in a rapidly changing, fast-paced setting. We are looking for a self-starter that will help drive our achondroplasia program through to MAA and NDA filings and drive successful execution of our regulatory plans. Previous experience in a regulatory project management role within the pharmaceutical or biotech industry & experience with filings are a must.